BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18448691)

  • 1. Detection of caspofungin resistance in Candida spp. by Etest.
    Desnos-Ollivier M; Dromer F; Dannaoui E
    J Clin Microbiol; 2008 Jul; 46(7):2389-92. PubMed ID: 18448691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints.
    Arendrup MC; Pfaller MA;
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3965-8. PubMed ID: 22564836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.
    Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
    J Clin Microbiol; 2001 Dec; 39(12):4387-9. PubMed ID: 11724849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro susceptibility of clinical isolates of Candida paparsilosis complex and other Candida species to caspofungin and anidulafungin by Etest.
    Khan Z; Ahmad S; Joseph L; Chandy R; Theyyathel A
    J Chemother; 2011 Apr; 23(2):97-101. PubMed ID: 21571626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates.
    Espinel-Ingroff A; Canton E; Peman J; Martín-Mazuelo E
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1347-50. PubMed ID: 20028814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media.
    Arendrup MC; Garcia-Effron G; Lass-Flörl C; Lopez AG; Rodriguez-Tudela JL; Cuenca-Estrella M; Perlin DS
    Antimicrob Agents Chemother; 2010 Jan; 54(1):426-39. PubMed ID: 19884370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of resistance to amphotericin B and caspofungin in Candida spp.: experimental study.
    Soler L; Pastor E; Rodriguez JC; Ruiz M; Lopez P; Cremades R; Royo G
    J Chemother; 2009 Aug; 21(4):467-9. PubMed ID: 19622473
    [No Abstract]   [Full Text] [Related]  

  • 10. Caspofungin disk diffusion breakpoints and quality control.
    Brown SD; Traczewski MM
    J Clin Microbiol; 2008 Jun; 46(6):1927-9. PubMed ID: 18400918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
    Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp.
    Cretella D; Barber KE; King ST; Stover KR
    J Med Microbiol; 2016 Dec; 65(12):1445-1451. PubMed ID: 27902377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-kill studies investigating the killing activity of caspofungin against Candida dubliniensis: comparing RPMI-1640 and antibiotic medium 3.
    Varga I; Sóczó G; Kardos G; Majoros L
    J Antimicrob Chemother; 2008 Jul; 62(1):149-52. PubMed ID: 18390882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.
    Staab JF; Neofytos D; Rhee P; Jiménez-Ortigosa C; Zhang SX; Perlin DS; Marr KA
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5421-7. PubMed ID: 24982083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media.
    Varga I; Sóczó G; Kardos G; Kemény-Beke A; Kelentey B; Márton I; Majoros L
    J Chemother; 2009 Feb; 21(1):36-41. PubMed ID: 19297270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influences of methodological variables on susceptibility testing of caspofungin against Candida species and Aspergillus fumigatus.
    Bartizal C; Odds FC
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2100-7. PubMed ID: 12821453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study.
    Cantón E; Pemán J; Gobernado M; Alvarez E; Baquero F; Cisterna R; Gil J; Martín-Mazuelos E; Rubio C; Sánchez-Sousa A; Serrano C
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1604-7. PubMed ID: 15793151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin.
    Marcos-Zambrano LJ; Escribano P; Rueda C; Zaragoza Ó; Bouza E; Guinea J
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5767-70. PubMed ID: 23979756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria.
    Aigner M; Erbeznik T; Gschwentner M; Lass-Flörl C
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.